Jun 30, 2020 5:05pm EDT IMV maintains the remainder of its At-the-Market Facility under its new Base Shelf Prospectus
Jun 19, 2020 4:26pm EDT IMV Files Preliminary Base Shelf Prospectus to Replace Expiring Base Shelf Prospectus
Jun 15, 2020 7:05am EDT IMV Announces Leading Independent Proxy Advisory Firms Recommend Shareholders Vote FOR All Resolutions at Upcoming Annual and Special Meeting
May 29, 2020 8:05am EDT Clinical Response and Translational Data from DeCidE1, a Phase 2 Study of DPX-Survivac Immunotherapy in Patients with Advanced Recurrent Ovarian Cancer
May 21, 2020 7:05am EDT IMV Announces Selection of a Vaccine Candidate Against COVID-19 to Advance Into Human Clinical Studies
May 15, 2020 7:05am EDT IMV Inc. Provides Clinical and Operational Update and Announces First Quarter 2020 Financial Results
May 04, 2020 7:05am EDT IMV Inc. to Announce First Quarter 2020 Results and Host a Conference Call and Webcast on May 15, 2020
